HWN Suggests

Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030

Annually, more than 1.5 million preventable new hepatitis B (HBV) infections continue to occur, with an estimated global burden of 296 million individuals living with chronic hepatitis B infection. This substantial health challenge results in over 820,000 annual deaths being attributed to complications such as liver cirrhosis and hepatocellular carcinoma (HCC). The HBV vaccination remains the cornerstone of public health policy to prevent chronic hepatitis B and its related complications. It serves as a crucial element in the global effort to eliminate HBV, as established by the World Health Organization (WHO), with an ambitious 90% vaccination target by 2030.

read full article

Featured

 RFK Jr., CDC panel have been casting doubt on the hepatitis B vaccine. Here's why it's safe

Chin-Hong said that by adding vaccines to the immunization schedule, children have more protection against diseases compared to 10 or even 20 years ago, and the makeup of vaccines is also different. "The way that we're delivering the vaccines is very different," he said. "They're through smaller bits of the virus instead of the whole virus itself or bacteria. So, it means that infants are exposed to actually fewer antigens. or parts of the virus or bacteria, with better vaccines."

Articles of Interest

CDC advisers punt on hepatitis B vaccine vote, after changing guidance on MMRV

The panel, which advises the Centers for Disease Control and Prevention, also debated changes to the current recommendations for the hepatitis B vaccine. Although some on the panel seemed enthusiastic about pushing the first dose recommendation later in life, after some discussion on Friday morning, there was a small revolt against tackling this issue at all.

Dropping hepatitis B shots for newborns would ignore history and endanger children, scientists warn

It was the late 1980s and the American plan to combat hepatitis B wasn’t working. A vaccine had been available since 1982 and recommended for those deemed to be at highest risk, such as health care workers and men who have sex with men. But the infection rates had gone up, not down. When epidemiologists at the Centers for Disease Control and Prevention dug into the data, they noticed one figure that had stayed alarmingly stable: Between 30% and 40% of hepatitis B patients had no identifiable risk factors at all.

RFK Jr.’s New Vaccine Panel Casts Doubt on Hepatitis B Shot at Birth

While pregnant mothers are usually tested for HBV, results can be delayed or incorrect. As a result, vaccinating all infants at birth “acts as a safety net,” an archived CDC FAQ explains. Starting the vaccine series at birth also increases the chance that a child will complete the three-shot series. Claims appealing to the youth of babies and pointing to adult risk factors are common techniques used by activists to argue against hepatitis B vaccination. Preventing infection in childhood is particularly important, since babies and young children are far more likely than adults to be unable to clear the virus from their bodies and develop a chronic hepatitis B infection. These infections can cause serious problems, such as liver cancer or liver failure.

Should infants receive the Hepatitis B vaccine? Here's what the data says

About 20 years ago, a study found that boys vaccinated as newborns had three times greater odds of being reported with autism compared to boys vaccinated later or not at all. The study, led by Carolyn M. Gallagher and Melody S. Goodman, analyzed National Health Interview Survey data from 1997–2002. However, researchers stressed that they only found an association, not proof that the Hepatitis B vaccine causes autism. Larger, other studies from the CDC, WHO, and other groups have found no evidence that vaccines, including Hepatitis B, cause autism.

Hepatitis B risks vs vaccine risks

Physicians for Informed Consent (PIC) has recently released 2 education documents. The first is a Disease Information Statement for hepatitis B titled, “Hepatitis B: What Parents Need to Know,” and the second is a Vaccine Risk Statement for Hepatitis B titled, “Hepatitis B Vaccine: Is It Safer Than Hepatitis B?” These documents were developed to help people assess the risks of hepatitis B and its vaccine and make an informed decision on vaccination.

Hepatitis B vaccination : Myths and controversies

Hepatitis B has attracted a lot of attention in recent times. It has been suggested that it is a widely prevalent disease and an important cause of morbidity and mortality in our country. A dispassionate analysis of available data suggests that the prevalence of disease may be much less than believed hitherto, and the morbidity and mortality due to the disease may have been overestimated. Vertical transmission from mother to child at the time of delivery may be an important contributor to overall carrier rates in the community which warrants that the first dose of vaccine be administered within 24–48 hours of birth to all newborns.

In Hepatitis B Vaccine Debate, CDC Panel Sidesteps Key Exposure Risk

“This is a very, very important vaccine that should be given to the high-risk populations,” said ACIP voting member Retsef Levi, a professor of operations management at the MIT Sloan School of Management. “The high-risk populations seem to be babies born to hep B-positive mothers, drug addicts, and other populations at high risk,” he said, despite Langer’s presentation highlighting other avenues of possible transmission.

Options for HBV Vaccine Non-Responders

Are you a hepatitis B vaccine non-responder? Approximately 5-15% of people who receive the vaccine are considered non-responders. This is especially important for health care workers, families living in households with people that have HBV, and others who may be at increased risk of exposure to HBV.

The 3-Shot HBV Vaccine – Do I Need to Restart the Series if I Am Off the Recommended Schedule?

If your immunity is greater than 10 IU/l, then you have adequate immunity which is thought to confer lifetime immunity, but studies so far show 20 years. This is because these studies are on-going!

Why Do Babies Need the Hepatitis B Vaccine?

The first dose of the vaccine protects newborns from possible exposures during delivery and the first few days of life. It provides a safety net for babies whose family members may not know they are infected with hepatitis B. If babies get infected with hepatitis B, they have a 90% chance of developing chronic hepatitis B. A baby can get infected during labor if the mother has hepatitis B. Infants can also get hepatitis B if they come in contact with body fluids from someone infected.

Resources

Hepatitis B Vaccine Schedules

Since 1991, ALL medically stable infants with a birth weight of at least 2,000 g in the U.S. are recommended to receive the first dose of hepatitis B vaccine within 24 hours of birth. The additional 2 doses are given at 1 month and 6 months of age.